NO148417C - Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzamider - Google Patents

Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzamider

Info

Publication number
NO148417C
NO148417C NO770488A NO770488A NO148417C NO 148417 C NO148417 C NO 148417C NO 770488 A NO770488 A NO 770488A NO 770488 A NO770488 A NO 770488A NO 148417 C NO148417 C NO 148417C
Authority
NO
Norway
Prior art keywords
preparation
new therapeutic
therapeutic active
analogy procedure
benzamides
Prior art date
Application number
NO770488A
Other languages
English (en)
Norwegian (no)
Other versions
NO148417B (no
NO770488L (no
Inventor
Willy Burkard
Pierre-Charles Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO770488L publication Critical patent/NO770488L/no
Publication of NO148417B publication Critical patent/NO148417B/no
Publication of NO148417C publication Critical patent/NO148417C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO770488A 1976-02-16 1977-02-15 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzamider NO148417C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT107076A AT345842B (de) 1976-02-16 1976-02-16 Verfahren zur herstellung von neuen morpholinderivaten, ihren n-oxyden und salzen

Publications (3)

Publication Number Publication Date
NO770488L NO770488L (no) 1977-08-17
NO148417B NO148417B (no) 1983-06-27
NO148417C true NO148417C (no) 1983-10-12

Family

ID=3505951

Family Applications (2)

Application Number Title Priority Date Filing Date
NO770488A NO148417C (no) 1976-02-16 1977-02-15 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzamider
NO1994008C NO1994008I1 (no) 1976-02-16 1994-08-03 Moklobemid/ 4-klor-N-(2-(4-morfolinyl)-etyl)benzamid

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1994008C NO1994008I1 (no) 1976-02-16 1994-08-03 Moklobemid/ 4-klor-N-(2-(4-morfolinyl)-etyl)benzamid

Country Status (28)

Country Link
JP (1) JPS52100476A (es)
AR (2) AR214307A1 (es)
AT (5) AT345842B (es)
AU (1) AU506427B2 (es)
BE (1) BE851422A (es)
CA (1) CA1076112A (es)
CH (5) CH623317A5 (es)
DE (1) DE2706179C2 (es)
DK (1) DK148824C (es)
ES (4) ES455907A1 (es)
FI (1) FI65426C (es)
FR (1) FR2340940A1 (es)
GB (1) GB1512194A (es)
GR (1) GR62413B (es)
HR (1) HRP930495B1 (es)
IE (1) IE44482B1 (es)
IL (1) IL51406A (es)
LU (2) LU76771A1 (es)
MC (1) MC1136A1 (es)
NL (2) NL179382C (es)
NO (2) NO148417C (es)
NZ (1) NZ183316A (es)
PH (1) PH12847A (es)
PT (1) PT66195B (es)
SE (1) SE426822B (es)
SI (1) SI7710060A8 (es)
YU (1) YU39983B (es)
ZA (1) ZA77746B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4829506B2 (ja) * 2004-02-17 2011-12-07 石原産業株式会社 チオアミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
ATE414694T1 (de) * 2005-05-03 2008-12-15 Bayer Cropscience Sa Neue heterocyclylethylbenzamid-derivate
RU2570898C2 (ru) * 2014-03-27 2015-12-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский химико-технологический университет имени Д.И. Менделеева (РХТУ им. Д.И. Менделеева)" Способ получения n-[2-(морфолин-4-ил)этил]-4-хлорбензамида (варианты)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
FR1501846A (fr) * 1966-09-26 1967-11-18 Bellon Labor Sa Roger Procédé amélioré pour la préparation des thioamides
US3787419A (en) * 1971-07-01 1974-01-22 American Home Prod N-substituted-alpha,alpha,alpha-trifluoro-m-toluamides

Also Published As

Publication number Publication date
IL51406A0 (en) 1977-04-29
CA1076112A (en) 1980-04-22
DK51677A (da) 1977-08-17
ES467449A1 (es) 1978-10-16
HRP930495B1 (en) 1996-10-31
ES455907A1 (es) 1978-05-01
NL179382B (nl) 1986-04-01
ATA107076A (de) 1978-02-15
IE44482B1 (en) 1981-12-16
AT345842B (de) 1978-10-10
AT349481B (de) 1979-04-10
SE7701669L (sv) 1977-08-17
NL930082I2 (nl) 1994-08-16
LU88300I2 (de) 1994-09-09
YU6077A (en) 1983-01-21
MC1136A1 (fr) 1977-11-18
NL930082I1 (nl) 1993-09-16
AT349479B (de) 1979-04-10
NZ183316A (en) 1979-04-26
BE851422A (fr) 1977-08-16
SE426822B (sv) 1983-02-14
FI65426C (fi) 1984-05-10
ZA77746B (en) 1977-12-28
JPS6215547B2 (es) 1987-04-08
FR2340940B1 (es) 1981-01-09
LU76771A1 (es) 1978-04-13
GR62413B (en) 1979-04-11
ATA25778A (de) 1978-09-15
AR212554A1 (es) 1978-07-31
NO1994008I1 (no) 1994-08-03
IL51406A (en) 1979-12-30
DK148824B (da) 1985-10-14
AU506427B2 (en) 1980-01-03
AR214307A1 (es) 1979-05-31
PH12847A (en) 1979-09-12
DK148824C (da) 1986-04-21
GB1512194A (en) 1978-05-24
ATA25878A (de) 1978-09-15
DE2706179C2 (de) 1984-02-02
CH623576A5 (en) 1981-06-15
PT66195B (fr) 1979-01-17
IE44482L (en) 1977-08-16
NL7701144A (nl) 1977-08-18
NO148417B (no) 1983-06-27
AT349480B (de) 1979-04-10
ATA25678A (de) 1978-09-15
CH623577A5 (en) 1981-06-15
FR2340940A1 (fr) 1977-09-09
NL179382C (nl) 1986-09-01
CH623317A5 (en) 1981-05-29
PT66195A (fr) 1977-03-01
FI65426B (fi) 1984-01-31
YU39983B (en) 1985-06-30
DE2706179A1 (de) 1977-08-18
FI770356A (es) 1977-08-17
CH622787A5 (en) 1981-04-30
AU2109977A (en) 1978-07-13
ES467455A1 (es) 1978-10-16
AT349482B (de) 1979-04-10
SI7710060A8 (en) 1996-12-31
ATA25578A (de) 1978-09-15
CH622786A5 (en) 1981-04-30
JPS52100476A (en) 1977-08-23
NO770488L (no) 1977-08-17
ES467448A1 (es) 1978-10-16

Similar Documents

Publication Publication Date Title
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO151320C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO146392C (no) Analogifremgangsmaate ved fremstilling av nye analgesisk aktive n-acetyl-para-aminofenyl-n`-acetyl-aminoalkansyreester-derivater
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO147523C (no) Analogifremgangsmaate ved fremstilling av et nytt terapeutisk aktivt piperidylindenderivat
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO148417C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzamider
NO147749C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropaner
NO148597C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-klorprednisolonderivater
NO144019C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridinderivater
NO150040C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner
NO146600C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater
NO141408C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzylpyrimidiner
NO145538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-forbindelser